OHSU in the news

Pandemic-driven innovations: What hospitals should keep

Today's Hospitalist May 16, 2022
In an article on pandemic-driven innovations that hospitals should continue, Stephanie Halvorson, M.D., says OHSU's ED has for years been admitting patients to its two partner community hospitals, but “we never did a lot of transfers of existing inpatients until we had covid surges and needed to free up inpatient beds." Once OHSU started transferring those patients to a unit at an affiliated hospital, "that saved more than 300 inpatient days at the academic center in just the first few months,” she said.

OHSU on-demand buprenorphine clinic reaches every corner of Oregon

EurekAlert May 16, 2022
An OHSU clinic launched in 2019 to provide easy access for people seeking medication to treat opioid use disorder switched to virtual-only service during the pandemic; a newly published study indicates many patients prefer virtual appointments, and Bradley Buchheit, M.D., says: "Virtual visits were perceived by participants as a valuable and critical option for accessing treatment. While many participants preferred virtual visits, some favored face-to-face visits due to relational and physical interactions with providers.”

Pediatrician shares advice for parents struggling with formula shortage

KPTV May 16, 2022
Ben Hoffman, M.D., provides guidance for parents struggling to find infant formula amid the nationwide shortage: “This is a crisis and it doesn’t seem like there is going to be an easy way out and I feel for all of those parents. Formula is designed specifically to be as close to human breast milk as it can be and anything that we do that doesn’t follow the specific recommendations from the manufacturer about how to add water, etc., can make it dangerous for babies.”

Bupivacaine Following Mohs Surgery Reduces Opioid Use

Medscape May 16, 2022
A randomized trial shows an injection of bupivacaine following Mohs micrographic surgery procedures significantly reduces pain scores and the use of post-surgery narcotics; Justin Leitenberger, M.D., says: "Bupivacaine, in this study, shows promise to provide longer lasting pain control from the surgical appointment and easier bridging to nonopioid pain control."

OHSU students in La Grande set to embark on Global Brigades trip to Honduras

The La Grande Observer May 14, 2022
Nine nursing students on the School of Nursing's La Grande campus will travel to Honduras to take part in an international service project focused on health-related outreach and sustainable development; nursing student Jessica Norton says, “For most of us, we are wanting to be able to have more experience caring for a more diverse population. We’d like to gain that experience with a more diverse community and increase access to the care that they’re unable to receive.”

The Truth About Whether Plan B Works if You’re Over 155 Pounds

Slate May 12, 2022
In a Slate article that explores the assertion that if one weighs more than 155 pounds, Plan B is ineffective; Alison Edelman, M.D., says it’s not that Plan B doesn’t work after a certain weight, per se, it's that weight “is a risk factor for emergency contraception failure.”

The Future Of Vision And Eye Care

Medical Futurist May 10, 2022
A story about the future of vision and eye care notes the OHSU Casey Eye Institute performed the first in vivo CRISPR gene therapy procedure in 2020 as part of a clinical trial to evaluate a potential treatment for a rare genetic mutation that severely impairs vision.

IUD Insertion: What to know before

The New York Times May 10, 2022
Maria Rodriguez, M.D., discusses options to make insertion of intrauterine devices, or IUDs, more comfortable for patients
See more stories